Institute of Pharmacy and Molecular Biotechnology Department Pharmaceutical Bioanalytics
Molecular mechanisms of drugs and cell metabolism in diseases and drug administration
Prof. Dr. Stefan Wölfl's research group works on projects in pharmaceutical biology, bioanalytics and molecular biology. They investigate the molecular mechanisms of drug effects, cell metabolism and cellular differentiation. Using genomics, proteomics and other bioanalytical methods, they investigate the mechanisms of action of drugs in various diseases such as cancer. The group is also involved in collaborative research projects and develops biosensors and organ-on-chip systems for biomedical research and drug testing.
Research Topics
The group's research projects include the identification of new (anti-cancer) drugs, the development of biosensors to combine cell-based assays, detection technologies to investigate the role of BMP signaling in cancer and the study of the effects of cell metabolism on drug treatment, toxicity and disease development. They are also working on the development of small molecules for reprogramming and cell differentiation, as well as biosensors for genotoxicity, cytotoxicity and environmental monitoring. In addition, they develop tools to analyze signal transduction networks.
Links
Information for applicants
The Pharmaceutical Bioanalytics working group is open to applications for Bachelor's and Master's theses and internships. For inquiries, please contact Ms. Petra Fellhauer.